Home › Conditions › Hyperosmolar Hyperglycaemic State (HHS)
endocrine
Hyperosmolar Hyperglycaemic State (HHS)
HHS is a hyperglycaemic emergency in type 2 diabetes characterised by glucose >30 mmol/L, osmolality >320 mOsm/kg, profound dehydration (average 8–10 litres), and minimal ketosis. Unlike DKA, correction must be slow (over 48 hours) to prevent…
JBDS HHS Guideline 2012 (updated 2023)
The pathway
1 · Diagnosis and initial assessment
- Glucose >30 mmol/L (often 40–60)
- Osmolality >320 mOsm/kg: calculate as 2(Na + K) + urea + glucose
- Ketones: typically <3 mmol/L blood ketones (vs DKA where >3)
- pH >7.3, bicarbonate >15 (vs DKA which is acidotic)
- ABG, U&E, FBC, blood cultures, urine culture
- ECG: look for hypokalaemia or precipitating ACS
2 · IV fluid resuscitation — slow and careful
- 0.9% NaCl is first-line (NOT 0.45% NaCl initially)
- 1 litre over 1 hour if haemodynamically compromised
- Then 0.9% NaCl 500ml/hr for next 4 hours
- Target: osmolality fall of 3–8 mOsm/kg/hour — NO faster
- Do NOT correct glucose faster than 5 mmol/L/hour
- Switch to 0.45% NaCl only if osmolality not falling despite adequate 0.9% NaCl
- Do NOT use rapid large-volume resuscitation — risk of cerebral oedema
3 · Insulin — timing matters
- Do NOT start insulin in first hour — fluids alone will lower glucose
- Insulin indicated only if:
- Blood ketones >1 mmol/L, OR
- Rate of glucose fall <5 mmol/L/hour after 1h of fluids
- Fixed-rate insulin infusion (FRII): 0.05 units/kg/hr (NOT the 0.1 units/kg/hr used in DKA)
- Target glucose fall: 5 mmol/L/hour — no faster
- Add 5% glucose when glucose <14 mmol/L to allow continued insulin
4 · Potassium replacement
- Check K⁺ before starting insulin
- K⁺ >5.5: no replacement
- K⁺ 3.5–5.5: 40 mmol/L in IV fluid
- K⁺ <3.5: urgent replacement before insulin — senior review
- Recheck K⁺ hourly while on insulin infusion
5 · VTE prophylaxis — critical
- Enoxaparin 40mg SC (prophylactic) on admission unless contraindicated
- HHS carries very high thrombosis risk (hyperviscosity from dehydration)
- If haematocrit markedly elevated → consider therapeutic dose LMWH after senior review
- Continue throughout admission
6 · Treat the precipitant
- Infection (most common): blood/urine cultures → antibiotics per local guidelines
- ACS: 12-lead ECG, troponin, cardiology input
- Stroke: FAST assessment, CT head
- Medications: review for culprit drugs (steroids, thiazides, antipsychotics)
- New T2DM: HHS may be the presenting event — diabetes team referral
7 · Monitoring frequency
- Glucose and ketones: hourly
- Osmolality: hourly for the first 6 hours, then 2-hourly for the next 6 (JBDS)
- Urine output: catheterise — target >0.5 ml/kg/hr
- Neurological obs: hourly — deterioration = cerebral oedema, call senior
- Target at 24h: osmolality <315, glucose 14–20 mmol/L
- Target at 48h: glucose 10–14 mmol/L, osmolality normal
Drugs
| Drug | Dose | Route | Notes |
|---|---|---|---|
| 0.9% Sodium Chloride | 500ml/hr initially | IV | First-line fluid. Do NOT use 0.45% NaCl initially. Slow correction over 48 hours. Target osmolality fall 3–8 mOsm/kg/hr. |
| Insulin (Actrapid) | 0.05 units/kg/hr | IV infusion | Not in first hour. Start only if ketones >1 or glucose not falling. Half the DKA rate. Avoid dropping glucose >5 mmol/L/hr. |
| Potassium chloride | 40 mmol/L in IV fluid | IV | If K⁺ 3.5–5.5 mmol/L before/during insulin. Check hourly on insulin infusion. |
| Enoxaparin | 40mg OD SC (prophylactic) | SC | Start on admission. Very high VTE risk. May need therapeutic dose if haematocrit very elevated — senior review. |
When to escalate
Osmolality >350 mOsm/kg (JBDS marker of severity) — HDU/level 2 and immediate senior review; also Na >160, pH <7.1, GCS <12, SBP <90, urine output <0.5ml/kg/hr,Neurological deterioration during treatment — cerebral oedema; stop insulin, reduce fluid rate, mannitol 0.5–1g/kg IV, CT head,K+ <3.0 mmol/L — hold insulin, urgent potassium replacement, senior review,Haemodynamic instability despite fluids — vasopressors, ITU referral,Concurrent ACS identified on ECG — dual pathway activation: HHS + ACS management,No improvement in osmolality at 4 hours — reassess fluid strategy, consider 0.45% NaCl, endocrinology review
Reference: JBDS HHS Guideline 2012 / NHS Diabetes Inpatient Guideline 2023
This page is the reference half
The app adds what a web page cannot: a VINDICATE differential builder, worked on-call scenarios with full A–E findings, recall practice, and all of it offline.